Contraceptive Options Following Gestational Diabetes: Current Perspectives

Area of Science:

• Reproductive Health
• Endocrinology
• Contraception

Background:

• Gestational diabetes mellitus (GDM) affects about 7% of US pregnancies.
• Women with GDM have an increased risk of developing type 2 diabetes mellitus later in life.
• Specialized contraceptive considerations are necessary for women with a history of GDM.

Purpose of the Study:

• To review the safety and effectiveness of contraceptive methods for women with a history of GDM.
• To highlight the importance of comprehensive counseling regarding reproductive health and future pregnancy planning for these women.

Main Methods:

• Review of existing clinical evidence on hormonal contraception and metabolic effects.
• Analysis of US Medical Eligibility Criteria for contraceptive methods in women with GDM.
• Consideration of GDM's implications on future health comorbidities.

Main Results:

• GDM has a Category 1 rating in US MEC, indicating safety for all contraceptive methods, but effectiveness varies.
• Limited evidence suggests hormonal contraception does not significantly adversely affect weight, lipids, or glucose metabolism.
• No clear relationship is established between hormonal contraceptive use and the development of type 2 diabetes mellitus.

Conclusions:

• Data are limited, making broad recommendations challenging.
• Contraceptive counseling for women with GDM history must include discussions on comorbidities like obesity and cardiovascular disease.
• Emphasizing highly effective contraception is crucial for optimizing future pregnancy timing and outcomes.